Rattlesnake blood discovery offers new antivenom potential

Researchers have identified a potent new antivenom candidate by isolating specialized molecules from rattlesnake blood. These proteins, which western diamondback rattlesnakes evolved to protect themselves from their own venom, demonstrate a natural ability to neutralize lethal toxins.

This discovery, led by University of Maryland Professor Sean B. Carroll and published in the Proceedings of the National Academy of Sciences, offers a potential solution to the limitations of current treatments. Traditional antivenoms are typically produced using antibodies from hyperimmunized horses or sheep, which can trigger adverse immunological reactions such as serum sickness and vary in effectiveness against different regional toxins.

Snakebites remain a significant global health threat, with the World Health Organization estimating annual deaths between 80,000 and 140,000. The new approach of using endogenous neutralizing factors could lead to more effective, scalable, and safer therapeutic derivatives for treating severe envenomation and preventing permanent disabilities.